Free Virtual Consultations. Corona Virus Related Cases Click Here.

1 Killed in Crash on 405 Freeway at Bel Air Crest Road

2 Cars Involved in Fatal Los Angeles Accident

Fatal Accident 7

Los Angeles, CA (October 8, 2019) – One person was killed in a crash in Los Angeles. The fatal accident occurred on the morning of October 8 on the 405 Freeway.

Two vehicles collided on northbound 405 Freeway at Bel Air Crest Road, in the Sepulveda Pass. One person was killed in the accident. Wreckage from the crash scattered across several lanes.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Los Angeles


October 10, 2019

Woman Injured in Crash on Highway 99 Near East 20th Avenue

Woman Hits Tree in Chico Accident Chico, CA (October 9, 2019) – A woman was i...

November 6, 2019

Kalya Vallez Killed in Crash on Highway 120 Near U.S. 395

Car Goes Down Embankment in Fatal Lee Vining Accident...

February 4, 2020

Woman Killed in Crash on La Cruz Drive

Car Rolls Down Embankment in Fatal La Mesa Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.